Tanke Biosciences Corporation

TNBI · OTC
Analyze with AI
6/30/2025
3/31/2025
12/31/2024
9/30/2024
Operating Activities
Net Income-$66-$99-$58-$23
Dep. & Amort.$1$1$1$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$64$93$40$20
Other Non-Cash$0$0-$23$23
Operating Cash Flow-$1-$5-$41$21
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$43-$1$5
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$0$16$0
Financing Cash Flow-$0$43$15$5
Forex Effect$0$0$26-$26
Net Chg. in Cash-$1$38$0-$1
Supplemental Information
Beg. Cash$38$0$0$1
End Cash$37$38$0$0
Free Cash Flow-$1-$5-$41$21